Library — CRISPR Gene Editing← All articles

Health Professional

CRISPR Gene Editing

Educational summary for professional readers. Verify against the primary literature and current product labelling before applying any of it clinically.

CRISPR Gene Editing

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a revolutionary gene-editing tool adapted from a natural bacterial defense system.

Principle

CRISPR uses an enzyme (usually Cas9) guided by a short RNA sequence to find and cut specific DNA regions, allowing precise gene modification.

How Produced

Scientists design guide RNAs that match the target DNA. The Cas9 protein and guide RNA are delivered into cells via plasmids, viral vectors, or nanoparticles.

Structure

A CRISPR system includes:

  • Guide RNA (gRNA)
  • Cas9 nuclease (DNA-cutting enzyme)
  • Delivery system

Clinical Indications

Being explored for genetic diseases (e.g., sickle cell anemia, β-thalassemia), cancer immunotherapy, and infectious diseases like HIV.

Mechanism of Action

The gRNA directs Cas9 to the exact DNA site, where it cuts the DNA. The cell's repair processes then disable or correct the gene.

Benefits

  • Precise gene targeting
  • Potential one-time cures
  • Wide research applications

Toxicities and Management

  • Off-target effects
  • Immune reactions
  • Managed by careful design and delivery methods

Challenges

  • Ethical concerns (germline editing)
  • Delivery to target tissues
  • Long-term safety

Future Directions

Safer, more accurate edits; in vivo applications; treating more genetic disorders.

Conclusion

CRISPR holds promise for curing genetic diseases and transforming medicine but must be used responsibly.

Health ProfessionalCSIR-CDRI does not run, fund, review, or endorse this website.Report a problem